S
Surgical Science Sweden AB
STO:SUS
Surgical Science Sweden AB
STO:SUS
Price:
31.6
SEK
-2.29%
Market Closed
Market Cap:
kr1.6B
Balance Sheet
Balance Sheet Decomposition
Surgical Science Sweden AB
Surgical Science Sweden AB
Balance Sheet Decomposition is not available for
Surgical Science Sweden AB
Surgical Science Sweden AB
Balance Sheet
Surgical Science Sweden AB
Surgical Science Sweden AB
Currency: SEK
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
0
|
2
|
4
|
39
|
38
|
69
|
87
|
317
|
434
|
634
|
968
|
616
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
634
|
968
|
616
|
|
| Cash Equivalents |
0
|
2
|
4
|
39
|
38
|
69
|
87
|
317
|
434
|
0
|
0
|
0
|
|
| Total Receivables |
17
|
17
|
17
|
11
|
15
|
32
|
32
|
180
|
244
|
192
|
254
|
208
|
|
| Accounts Receivables |
14
|
13
|
13
|
8
|
12
|
30
|
28
|
157
|
226
|
173
|
211
|
137
|
|
| Other Receivables |
2
|
4
|
4
|
3
|
3
|
3
|
5
|
22
|
18
|
19
|
44
|
71
|
|
| Inventory |
3
|
4
|
6
|
8
|
5
|
7
|
12
|
113
|
135
|
154
|
180
|
206
|
|
| Other Current Assets |
1
|
2
|
0
|
2
|
2
|
4
|
2
|
7
|
14
|
11
|
24
|
154
|
|
| Total Current Assets |
21
|
25
|
27
|
60
|
60
|
113
|
133
|
617
|
826
|
991
|
1 426
|
1 185
|
|
| PP&E Net |
2
|
2
|
1
|
3
|
4
|
9
|
9
|
38
|
51
|
77
|
102
|
106
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
4
|
9
|
9
|
38
|
51
|
77
|
102
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
4
|
6
|
8
|
20
|
40
|
56
|
85
|
0
|
|
| Intangible Assets |
27
|
28
|
31
|
28
|
25
|
67
|
63
|
274
|
301
|
287
|
312
|
301
|
|
| Goodwill |
0
|
0
|
0
|
5
|
5
|
260
|
260
|
3 019
|
3 444
|
3 329
|
3 616
|
3 077
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
4
|
5
|
8
|
9
|
|
| Other Long-Term Assets |
0
|
0
|
4
|
6
|
6
|
7
|
7
|
25
|
22
|
15
|
16
|
14
|
|
| Other Assets |
0
|
0
|
0
|
5
|
5
|
260
|
260
|
3 019
|
3 444
|
3 329
|
3 616
|
3 077
|
|
| Total Assets |
49
N/A
|
55
+11%
|
64
+16%
|
101
+59%
|
100
-2%
|
456
+358%
|
472
+4%
|
3 978
+742%
|
4 650
+17%
|
4 703
+1%
|
5 480
+17%
|
4 691
-14%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
3
|
4
|
2
|
4
|
3
|
2
|
2
|
34
|
66
|
41
|
58
|
0
|
|
| Accrued Liabilities |
3
|
4
|
7
|
9
|
7
|
14
|
15
|
104
|
44
|
47
|
58
|
0
|
|
| Short-Term Debt |
2
|
4
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
15
|
13
|
19
|
0
|
|
| Other Current Liabilities |
3
|
2
|
4
|
2
|
6
|
23
|
14
|
81
|
181
|
133
|
378
|
291
|
|
| Total Current Liabilities |
12
|
13
|
22
|
14
|
16
|
40
|
31
|
232
|
306
|
235
|
513
|
291
|
|
| Long-Term Debt |
0
|
0
|
0
|
4
|
4
|
6
|
4
|
12
|
15
|
40
|
57
|
2
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
9
|
10
|
49
|
52
|
45
|
44
|
0
|
|
| Other Liabilities |
19
|
22
|
19
|
0
|
0
|
0
|
0
|
100
|
41
|
37
|
38
|
126
|
|
| Total Liabilities |
31
N/A
|
35
+15%
|
41
+18%
|
18
-56%
|
20
+11%
|
55
+169%
|
45
-17%
|
393
+769%
|
413
+5%
|
357
-13%
|
651
+82%
|
418
-36%
|
|
| Equity | |||||||||||||
| Common Stock |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
|
| Retained Earnings |
23
|
22
|
19
|
23
|
29
|
16
|
0
|
204
|
855
|
945
|
1 428
|
872
|
|
| Additional Paid In Capital |
0
|
41
|
41
|
105
|
107
|
416
|
426
|
3 379
|
3 379
|
3 398
|
3 398
|
3 398
|
|
| Other Equity |
41
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
19
N/A
|
20
+4%
|
22
+14%
|
83
+271%
|
79
-4%
|
402
+406%
|
427
+6%
|
3 585
+739%
|
4 236
+18%
|
4 345
+3%
|
4 829
+11%
|
4 273
-12%
|
|
| Total Liabilities & Equity |
49
N/A
|
55
+11%
|
64
+16%
|
101
+59%
|
100
-2%
|
456
+358%
|
472
+4%
|
3 978
+742%
|
4 650
+17%
|
4 703
+1%
|
5 480
+17%
|
4 691
-14%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
3
|
14
|
14
|
24
|
24
|
34
|
34
|
51
|
51
|
51
|
51
|
51
|
|
Switch to:
Switch to:
See Also
Discover More
